RiverFront Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$439K Buy
987
+375
+61% +$167K 0.01% 216
2025
Q1
$297K Buy
+612
New +$297K 0.01% 239
2021
Q3
Sell
-1,125
Closed -$227K 136
2021
Q2
$227K Buy
1,125
+44
+4% +$8.88K ﹤0.01% 135
2021
Q1
$232K Buy
1,081
+158
+17% +$33.9K ﹤0.01% 107
2020
Q4
$218K Buy
+923
New +$218K ﹤0.01% 90